肠外营养市场规模、份额、趋势分析报告:依阶段类型、营养类型、适应症、销售管道、地区、细分市场趋势,2023-2030
市场调查报告书
商品编码
1321393

肠外营养市场规模、份额、趋势分析报告:依阶段类型、营养类型、适应症、销售管道、地区、细分市场趋势,2023-2030

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Stage Type (Adults, Pediatrics), By Nutrient Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

肠外营养市场成长与趋势

Grand View Research, Inc.最新报告显示,到2030年,全球肠外营养市场规模预计将达到107亿美元,预测期内年复合成长率为6.0%。

癌症、糖尿病和其他神经系统疾病等慢性疾病的增加,危重患者基本营养缺乏的急剧增加,以及对医院相关营养不良的认识不断提高,是推动肠外营养采用增加的一些关键要素。 。肠外给药具有起效快、剂量低的优点,并且可以防止用餐不平衡引起的各种副作用,从而推动市场成长。

然而,给药过程中感染的高风险以及患者对经肠营养的偏好是限制市场成长的主要要素。随着人口的增加,家庭和国家的医疗保健和食品成本不断增加。因此,出生率上升预计将影响营养水平,从而成为市场促进因素。实现的出生率比绝对出生率(粗出生率)更重要,因为出生率包括环境以及资源压力,例如每次出生所需的水、食物和药物的数量发挥作用。过去十年来,实际出生率有所上升,预计在预测期内将保持成长。

国家卫生统计中心 (NCHS) 报告 2020 年出生率为每 1000 人 11.99 人。此外,低出生体重婴儿的比例8.0%,推动了全球对 PN 产品的需求。此外,60岁以上老年人口众多,免疫力低下,神经系统疾病、心臟病、癌症、脊柱损伤等的高发生率也是预测期内注射用脂肪乳市场的促进因素。 。这些人群预计将能够获得现代外科治疗,这有望延长寿命并增加对加护治疗和术后治疗的需求,包括脂肪乳剂等 PN 产品。

肠外营养市场报告亮点

  • 市场上营运的主要企业主要致力于提高病患安全。该公司也致力于透过结合条码辅助给药等技术来开发 PN 产品,以补充肠外营养配方。
  • 为患者提供改进的脂质和蛋白质配方的能力是公司将其产品与竞争分开来的关键参数之一。
  • 此外,感染率高、水质和卫生条件差以及缺乏认识是新兴国家营养不良发生率增加的常见要素,这对PN源产生了巨大的需求并增加了市场份额,从而促进了成长。
  • 2022年,由于副作用较少的新型氨基酸溶液的出现,单剂量氨基酸溶液营养剂类型主导了市场。
  • 到2022年,成人细分市场将占据最大份额,因为该年龄层的阿兹海默症、肌少症、癌症和糖尿病等各种慢性疾病的盛行率不断上升,因此越来越多地采用肠外营养产品。我做到了。
  • 由于克隆氏症、囊性纤维化、胰臟炎、其他癌症相关治疗和其他健康疾病的盛行率不断增加,其他适应症细分市场将在 2022 年占据主导地位。
  • 2022年,由于私人和公立医疗机构数量众多,慢性疾病患者增加,销售管道占据市场主导地位。
  • 由于慢性病和营养不良的罹患率上升,以及美国FDA 批准的增加,北美将在 2022 年主导全球市场。

目录

第1章调查方法和范围

  • 调查过程
  • 资讯采购
  • 调查方法
  • 调查范围和先决条件
  • 调查方法
  • 资料列表

第2章执行摘要

第3章肠外营养市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 附随市场预测
  • 从使用者观点分析
    • 消费行为分析
    • 市场影响力分析
  • 法律规范
    • 赎回框架
    • 标准和合规性
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
    • 产业挑战
  • 肠外营养市场分析工具
    • 产业分析-波特
    • PESTEL分析
  • COVID-19 对肠外营养市场的影响

第4章肠外营养市场:营养类型的估算与趋势分析

  • 细分仪表板
  • 肠外营养市场:2022 年和 2030 年营养类型变化分析
    • 碳水化合物
    • 肠外脂肪乳剂
    • 单剂量氨基酸溶液
    • 微量元素
    • 维生素和矿物质

第5章肠外营养市场:阶段类型估计与趋势分析

  • 细分仪表板
  • 肠外营养市场:2022 年和 2030 年阶段类型变化分析
    • 成人
    • 孩子

第6章肠外营养市场:适应症估计与估计/趋势分析

  • 细分仪表板
  • 肠外营养市场:2022 年及 2030 年适应症变化分析
    • 阿兹海默氏症
    • 营养缺乏
    • 癌症治疗
    • 糖尿病
    • 慢性肾臟病
    • 罕见疾病
    • 吞嚥困难
    • 疼痛管理
    • 吸收不良/胃肠道疾病/腹泻
    • 其他的

第7章肠外营养市场:销售管道估算及趋势分析

  • 细分仪表板
  • 肠外营养市场:2022年及2030年销售管道变化分析
    • 网上销售
    • 零售销售
    • 机构销售

第8章肠外营养市场:区域估计与趋势分析

  • 定义和范围
  • 2022 年及 2030 年区域市占率分析
  • 区域市场仪表板
  • 区域市场简介
  • 2022年至2030年市场规模、预测、收入及趋势分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲

第9章竞争形势

  • 公司分类
  • 主要企业市场分析
  • 主要企业市占率分析
  • 主要市场参与企业的最新发展和影响分析
  • 公司简介
    • Braun Melsungen AG
    • Fresenius kabi AG
    • Allergan
    • Grifols SA
    • Pfizer Inc.
    • Otsuka Pharmaceutical Factory, Inc
    • Baxter
    • Aculife
    • Sichuan Kelun Pharmaceutical Co., Ltd
    • Vifor Pharma
Product Code: 978-1-68038-867-1

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 10.7 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth.

However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. With the increasing population, healthcare costs and food expenditures for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition levels, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period.

In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide. Furthermore, the presence of a large population base, aged above 60 years, suffering from low immunity levels, and prone to incidence of neurological diseases, cardiac problems, cancers, and spinal injuries, is a high-impact rendering driver for the parenteral lipid emulsions market over the forecast period. This population is expected to avail the latest surgical treatments, which is expected to increase their life span, thereby driving the need for intensive care & postoperative treatment, inclusive of PN products, such as lipid emulsions.

Parenteral Nutrition Market Report Highlights

  • Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode-assisted medication.
  • The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors
  • Also, high infection rates, poor water quality & sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
  • The single-dose amino acid solution nutrient type segment dominated the market in 2022 due to the introduction of newly available amino acid solutions with minimal side effects
  • In 2022, the adult segment held the largest share due to increased adoption of parenteral nutrition products owing to the rising prevalence of various chronic diseases, such as Alzheimer's disease, sarcopenia, cancer, and diabetes among this age group
  • The others indication segment dominated the market in 2022 due to the increased prevalence of Crohn's disease, cystic fibrosis, pancreatitis, other cancer-related treatment, and other health ailments
  • In 2022, institutional sales channels dominated the market owing to the high number of private & public healthcare institutions and the increased patient population with chronic disease
  • North America dominated the global market in 2022 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Process
  • 1.2. Information Procurement
    • 1.2.1. Purchased database
      • 1.2.1.1. GVR's internal database
    • 1.2.2. Market Formulation & Validation
  • 1.3. Research Methodology
  • 1.4. Research Scope and Assumptions
  • 1.5. Research Methodology
    • 1.5.1. Region Market: CAGR Calculation
    • 1.5.2. Region Based Segment Share Calculation
  • 1.6. List To Data Nutrient Type

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights
  • 2.4. Parenteral Nutrition Market Snapshot

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer Behavior Analysis
    • 3.2.2. Market Influencer Analysis
  • 3.3. Regulatory Framework
    • 3.3.1. Reimbursement Framework
    • 3.3.2. Standard & Compliance
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenge
  • 3.5. Parenteral Nutrition Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Bargaining power of the suppliers
      • 3.5.1.2. Bargaining power of the buyers
      • 3.5.1.3. Threats of substitution
      • 3.5.1.4. Threats from new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Economic and Social landscape
      • 3.5.2.3. Technological landscape
  • 3.6. Impact of COVID 19 on Parenteral Nutrition Market

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Parenteral Nutrition Market: Nutrient Type Movement Analysis, 2022 & 2030 (USD Million)
    • 4.2.1. Carbohydrates
      • 4.2.1.1. Carbohydrates Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Parenteral Lipid Emulsion
      • 4.2.2.1. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Single Dose Amino Acid Solution
      • 4.2.3.1. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Trace Elements
      • 4.2.4.1. Trace Elements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Vitamins & Minerals
      • 4.2.5.1. Vitamins & Minerals Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Parenteral Nutrition Market: Stage Type Movement Analysis, 2022 & 2030 (USD Million)
    • 5.2.1. Adult
      • 5.2.1.1. Adult Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Pediatrics
      • 5.2.2.1. Pediatrics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Parenteral Nutrition Market: Indication Movement Analysis, 2022 & 2030 (USD Million)
    • 6.2.1. Alzheimer's
      • 6.2.1.1. Alzheimer's Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Nutrition Deficiency
      • 6.2.2.1. Nutrition Deficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Cancer Care
      • 6.2.3.1. Cancer Care Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Diabetes
      • 6.2.4.1. Diabetes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5. Chronic Kidney Disease
      • 6.2.5.1. Chronic Kidney Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6. Orphan Disease
      • 6.2.6.1. Orphan Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7. Dysphagia
      • 6.2.7.1. Dysphagia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.8. Pain Management
      • 6.2.8.1. Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.9. Malabsorption/GI Disorder/Diarrhea
      • 6.2.9.1. Malabsorption/GI Disorder/Diarrhea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.10. Others
      • 6.2.10.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Parenteral Nutrition Market: Sales Channel Movement Analysis, 2022 & 2030 (USD Million)
    • 7.2.1. Online Sales
      • 7.2.1.1. Online Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. Retail Sales
      • 7.2.2.1. Retail Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Institutional Sales
      • 7.2.3.1. Institutional Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis

  • 8.1. Definition & Scope
  • 8.2. Regional Market Share Analysis, 2022 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
    • 8.5.1. North America
      • 8.5.1.1. North America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.1.2. U.S.
      • 8.5.1.2.1. Key Country Dynamics
      • 8.5.1.2.2. Competitive Scenario
      • 8.5.1.2.3. Regulatory Framework
      • 8.5.1.2.4. Reimbursement Scenario
      • 8.5.1.2.5. U.S. Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.1.3. Canada
      • 8.5.1.3.1. Key Country Dynamics
      • 8.5.1.3.2. Competitive Scenario
      • 8.5.1.3.3. Regulatory Framework
      • 8.5.1.3.4. Reimbursement Scenario
      • 8.5.1.3.5. Canada Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2. Europe
      • 8.5.2.1. Europe Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.2. UK
      • 8.5.2.2.1. Key Country Dynamics
      • 8.5.2.2.2. Competitive Scenario
      • 8.5.2.2.3. Regulatory Framework
      • 8.5.2.2.4. Reimbursement Scenario
      • 8.5.2.2.5. UK Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.3. Germany
      • 8.5.2.3.1. Key Country Dynamics
      • 8.5.2.3.2. Competitive Scenario
      • 8.5.2.3.3. Regulatory Framework
      • 8.5.2.3.4. Reimbursement Scenario
      • 8.5.2.3.5. Germany Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.4. France
      • 8.5.2.4.1. Key Country Dynamics
      • 8.5.2.4.2. Competitive Scenario
      • 8.5.2.4.3. Regulatory Framework
      • 8.5.2.4.4. Reimbursement Scenario
      • 8.5.2.4.5. France Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.5. Italy
      • 8.5.2.5.1. Key Country Dynamics
      • 8.5.2.5.2. Competitive Scenario
      • 8.5.2.5.3. Regulatory Framework
      • 8.5.2.5.4. Reimbursement Scenario
      • 8.5.2.5.5. Italy Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.6. Spain
      • 8.5.2.6.1. Key Country Dynamics
      • 8.5.2.6.2. Competitive Scenario
      • 8.5.2.6.3. Regulatory Framework
      • 8.5.2.6.4. Reimbursement Scenario
      • 8.5.2.6.5. Spain Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.7. Denmark
      • 8.5.2.7.1. Key Country Dynamics
      • 8.5.2.7.2. Competitive Scenario
      • 8.5.2.7.3. Regulatory Framework
      • 8.5.2.7.4. Reimbursement Scenario
      • 8.5.2.7.5. Denmark Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.8. Sweden
      • 8.5.2.8.1. Key Country Dynamics
      • 8.5.2.8.2. Competitive Scenario
      • 8.5.2.8.3. Regulatory Framework
      • 8.5.2.8.4. Reimbursement Scenario
      • 8.5.2.8.5. Sweden Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.9. Norway
      • 8.5.2.9.1. Key Country Dynamics
      • 8.5.2.9.2. Competitive Scenario
      • 8.5.2.9.3. Regulatory Framework
      • 8.5.2.9.4. Reimbursement Scenario
      • 8.5.2.9.5. Norway Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Asia Pacific
      • 8.5.3.1. Asia Pacific Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.2. Japan
      • 8.5.3.2.1. Key Country Dynamics
      • 8.5.3.2.2. Competitive Scenario
      • 8.5.3.2.3. Regulatory Framework
      • 8.5.3.2.4. Reimbursement Scenario
      • 8.5.3.2.5. Japan Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.3. India
      • 8.5.3.3.1. Key Country Dynamics
      • 8.5.3.3.2. Competitive Scenario
      • 8.5.3.3.3. Regulatory Framework
      • 8.5.3.3.4. Reimbursement Scenario
      • 8.5.3.3.5. India Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.4. China
      • 8.5.3.4.1. Key Country Dynamics
      • 8.5.3.4.2. Competitive Scenario
      • 8.5.3.4.3. Regulatory Framework
      • 8.5.3.4.4. Reimbursement Scenario
      • 8.5.3.4.5. China Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.5. Australia
      • 8.5.3.5.1. Key Country Dynamics
      • 8.5.3.5.2. 8. 6. 3.5Competitive Scenario
      • 8.5.3.5.3. Regulatory Framework
      • 8.5.3.5.4. Reimbursement Scenario
      • 8.5.3.5.5. Australia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.6. Thailand
      • 8.5.3.6.1. Key Country Dynamics
      • 8.5.3.6.2. 8. Competitive Scenario
      • 8.5.3.6.3. Regulatory Framework
      • 8.5.3.6.4. Reimbursement Scenario
      • 8.5.3.6.5. Thailand Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.7. South Korea
      • 8.5.3.7.1. Key Country Dynamics
      • 8.5.3.7.2. 8. 6. 3.7Competitive Scenario
      • 8.5.3.7.3. Regulatory Framework
      • 8.5.3.7.4. Reimbursement Scenario
      • 8.5.3.7.5. South Korea Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6 Latin America
      • 8.5.6.1. Latin America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.6.2. Brazil
      • 8.5.6.2.1. Key Country Dynamics
      • 8.5.6.2.2. Competitive Scenario
      • 8.5.6.2.3. Regulatory Framework
      • 8.5.6.2.4. Reimbursement Scenario
      • 8.5.6.2.5. Brazil Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.6.3. Mexico
      • 8.5.6.3.1. Key Country Dynamics
      • 8.5.6.3.2. Competitive Scenario
      • 8.5.6.3.3. Regulatory Framework
      • 8.5.6.3.4. Reimbursement Scenario
      • 8.5.6.3.5. 6. 4.3.5 Mexico Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.6.4. Argentina
      • 8.5.6.4.1. Key Country Dynamics
      • 8.5.6.4.2. Competitive Scenario
      • 8.5.6.4.3. Regulatory Framework
      • 8.5.6.4.4. Reimbursement Scenario
      • 8.5.6.4.5. Argentina Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. MEA
      • 8.5.7.1. MEA Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.2. South Africa
      • 8.5.7.2.1. Key Country Dynamics
      • 8.5.7.2.2. Competitive Scenario
      • 8.5.7.2.3. Regulatory Framework
      • 8.5.7.2.4. Reimbursement Scenario
      • 8.5.7.2.5. South Africa Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.3. Saudi Arabia
      • 8.5.7.3.1. Key Country Dynamics
      • 8.5.7.3.2. Competitive Scenario
      • 8.5.7.3.3. Regulatory Framework
      • 8.5.7.3.4. Reimbursement Scenario
      • 8.5.7.3.5. Saudi Arabia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.4. UAE
      • 8.5.7.4.1. Key Country Dynamics
      • 8.5.7.4.2. Competitive Scenario
      • 8.5.7.4.3. Regulatory Framework
      • 8.5.7.4.4. Reimbursement Scenario
      • 8.5.7.4.5. UAE Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.5. Kuwait
      • 8.5.7.5.1. Key Country Dynamics
      • 8.5.7.5.2. Competitive Scenario
      • 8.5.7.5.3. Regulatory Framework
      • 8.5.7.5.4. Reimbursement Scenario
      • 8.5.7.5.5. Kuwait Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Key Company Market Position Analysis
  • 9.3. Key Company Market Share Analysis
  • 9.4. Recent Development and Impact Analysis, by key Market Participants
  • 9.5. Company Profiles
    • 9.5.1. Braun Melsungen AG
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Fresenius kabi AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Allergan
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols S.A.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Pfizer Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Otsuka Pharmaceutical Factory, Inc
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Baxter
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Aculife
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Sichuan Kelun Pharmaceutical Co., Ltd
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Vifor Pharma
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 4 North America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 5 North America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 6 North America Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 7 U.S. Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 9 U.S. Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 10 U.S. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 11 Canada Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 12 Canada Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 13 Canada Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 14 Canada Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 16 Europe Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 17 Europe Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 18 Europe Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 19 UK Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 20 UK Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 21 UK Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 22 UK Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 24 Germany Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 25 Germany Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 26 Germany Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 27 France Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 28 France Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 29 France Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 30 France Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 31 Italy Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 32 Italy Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 33 Italy Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 36 Spain Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 37 Spain Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 38 Spain Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 39 Sweden Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 41 Sweden Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 42 Sweden Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 43 Denmark Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 45 Denmark Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 46 Denmark Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 47 Norway Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 48 Norway Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 49 Norway Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 50 Norway Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 55 Japan Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 56 Japan Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 57 Japan Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 58 Japan Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 59 China Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 60 China Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 61 China Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 62 China Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 63 India Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 64 India Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 65 India Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 66 India Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 67 Australia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 68 Australia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 69 Australia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 70 Australia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 71 South Korea Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 72 South Korea Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 73 South Korea Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 74 South Korea Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 75 Thailand Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 76 Thailand Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 77 Thailand Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 78 Thailand Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 79 Latin America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 80 Latin America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 81 Latin America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 82 Latin America. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 83 Brazil Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 84 Brazil Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 85 Brazil Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 86 Brazil Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 87 Mexico Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 88 Mexico Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 89 Mexico Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 90 Mexico. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 91 Argentina Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 92 Argentina Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 93 Argentina Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 94 Argentina Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 95 MEA Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 96 MEA Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 97 MEA Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 98 MEA Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 99 South Africa Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 100 South Africa Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 101 South Africa Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 102 South Africa Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 107 UAE Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 108 UAE Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 109 UAE Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 110 UAE Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 111 Kuwait Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 112 Kuwait Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 113 Kuwait Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 114 Kuwait Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Parenteral nutrition market snapshot (2022)
  • Fig. 11 Parenteral nutrition market segmentation
  • Fig. 12 Parenteral nutrition market: Strategy framework
  • Fig. 13 Market trends and outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration & growth prospect mapping
  • Fig. 17 Market driver relevance analysis (Current & future impact)
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Parenteral nutrition market, nutrient type outlook: key takeaways (USD Million)
  • Fig. 20 Parenteral nutrition market: nutrient type movement analysis, 2022 & 2030 (USD Million)
  • Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Single dose amino acid solution market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Trace elements market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vitamins & Minerals market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 26 Parenteral nutrition market, stage type outlook: key takeaways (USD Million)
  • Fig. 27 Parenteral nutrition market: stage type movement analysis, 2022 & 2030 (USD Million)
  • Fig. 28 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Pediatrics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Parenteral nutrition market, Indication outlook: key takeaways (USD Million)
  • Fig. 31 Parenteral nutrition market: Indication movement analysis, 2022 & 2030 (USD Million)
  • Fig. 32 Alzheimer's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Nutrition Deficiency market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 34 Cancer Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Chronic kidney disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Orphan disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Dysphagia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pain management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Malabsorption/GI Disorder/Diarrhea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Parenteral nutrition market, regional marketplace: Key takeaways (USD Million)
  • Fig. 43 Parenteral nutrition market: regional movement analysis, 2022 & 2030 (USD Million)
  • Fig. 44 North America Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 MEA Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)